Human Immune Monitoring Core

$471,062U19FY2013AINIH

Stanford University, Stanford CA

Investigators

Linked publications & trials

Paper 37707792 Paper 35947979 Paper 34888528 Paper 34065617 Paper 33846272 Paper 33310880 Paper 31971918 Paper 31636302 Paper 31201239 Paper 30842675 Paper 30814336 Paper 30768832 Paper 29898768 Paper 29706550 Paper 29618496 Paper 28842433 Paper 28637924 Paper 28389038 Paper 28298564 Paper 28179497 Paper 28092664 Paper 27916977 Paper 27766961 Paper 27746093 Paper 27681619 Paper 27655870 Paper 27655845 Paper 27636738 Paper 27446979 Paper 27390767 Paper 27279139 Paper 27207787 Paper 27135045 Paper 27030598 Paper 27005435 Paper 26979955 Paper 26861911 Paper 26832412 Paper 26700767 Paper 26582264 Paper 26365387 Paper 26333287 Paper 26311730 Paper 26309181 Paper 26232539 Paper 26091718 Paper 26037552 Paper 25992863 Paper 25904912 Paper 25899688 Paper 25888703 Paper 25834109 Paper 25822800 Paper 25740957 Paper 25711758 Paper 25609839 Paper 25594173 Paper 25535378 Paper 25336731 Paper 25255099 Paper 25246558 Paper 25203448 Paper 25157137 Paper 24981332 Paper 24850730 Paper 24676204 Paper 24522699 Paper 24487923 Paper 24440389 Paper 24405293 Paper 24367114 Paper 24344260 Paper 24344259 Paper 24340001 Paper 24337376 Paper 24296720 Paper 24296590 Paper 24270423 Paper 24189842 Paper 24154599 Paper 24043759 Paper 23992996 Paper 23947350 Paper 23923050 Paper 23878218 Paper 23768493 Paper 23761790 Paper 23748502 Paper 23740815 Paper 23734205 Paper 23677590 Paper 23598398 Paper 23591775 Paper 23519642 Paper 23395677 Paper 23390249 Paper 23325887 Paper 23278741 Paper 23236163 Paper 23226205

Abstract

The role of the human immune monitoring core (HIMC, Core C) will be to (1) provide standardized, state-ofthe art Immune monitoring assays at the RNA, protein, and cellular level, to support research projects within the U19; (2) to test and develop new technologies for immune monitoring that may be useful In the context of the U19; and (3) to efficiently archive, report, and mine data from immune monitoring studies, so as to increase the value of the data and to assist In biomarker discovery. Specific Aim 1: Standardized, state-of-the-art immune monitoring assays. The HIMC has validated a set of Immune monitoring assays that will be available to U19 research projects. These include genome-wide RNA microarrays, multiplex Luminex cytokine assays, immunophenotyping, phosphoepitope flow cytometry, CFSE dye dilution assays for proliferation, and intracellular cytokine staining. An ELISPOT reader is also available for readout of ELISPOT assays. Specific Aim 2: New technology for immune monitoring. The HIMC is evaluating multiple new platforms with potential for immune monitoring, including: isoelectric focusing analysis of phosphoproteins (CellBiosciences); chemiluminescent cytokine detection (MesoScale Discovery); biomolecular interaction analysis (ForteBlo); multiplexed tetramer analysis; flow cytometry with time-of-flight mass spectrometry (CyTof); qPCR arrays on sorted cell populations (Fluidigm Blomark); and specialized microarrays for Immunologically relevant genes and for pathogen detection (Agilent). Specific Aim 3: Databaslng. The HIMC is Implementing the use of collaborative online databases for flow cytometry, Luminex, and microarray data, and is also evaluating data aggregation and mining programs such as Tibco Spotfire.

View original record on NIH RePORTER →